2009.09 – 2014.06 复旦大学药学院，药剂学专业，博士
2001.09 – 2005.01 复旦大学药学院，药剂学专业，硕士
1990.09 – 1995.07 上海医科大学药学院，药理学专业，学士
2015.12至今 复旦大学药学院，副教授
2000.06 - 2015.11 复旦大学药学院，讲师
1995.07 - 2000.05 上海医科大学药学院，助教
1. 脂质纳米递药系统研究
2. 肿瘤靶向诊疗药物研发
3. 放射性核素示踪技术在医药研究中的应用
围绕研究方向，以第一作者和通讯作者(含共同)在国内外学术刊物上发表科研论文20余篇。主持国家自然科学基金面上项目2项及省部级项目1项、新药研发项目2项、以研究骨干参与国家自然科学基金重点项目1项及多项上海市科委基础研究项目。获中国发明专利授权1项。
1. Ercan Wu#, Juan Guan#, Yifei Yu, Shiqi Lin, Tianhao Ding, Yuxiu Chu, Feng Pan, Mengyuan Liu, Yang Yang, Zui Zhang, Jian Zhang*, Changyou Zhan*, Jun Qian*. Exemplifying interspecies variation of liposome in vivo fate by the effects of anti-PEG antibodies. Acta Pharmaceutica Sinica B, 2024, 14(11): 4994-5007.
2. Yifei Yu, Ercan Wu, Shiqi Lin, Yuxiu Chu, Yang Yang, Feng Pan, Tianhao Ding, Jun Qian*, Kuan Jiang*, Changyou Zhan*. Reexamining the effects of drug loading on the in vivo performance of PEGylated liposomal doxorubicin. Acta Pharmacologica Sinica, 2024, 45(3): 646-659.
3. Feng Pan, Mengyuan Liu, Guanghui Li, Boqian Chen, Yuxiu Chu, Yang Yang, Ercan Wu, Yifei Yu, Shiqi Lin, Tianhao Ding, Xiaoli Wei*, Changyou Zhan*, Jun Qian*. Phospholipid type regulates protein corona composition and in vivo performance of lipid nanodiscs. Molecular Pharmaceutics, 2024, 21(5): 2272-2283.
4. Mengyuan Liu#, Ercan Wu#, Feng Pan, Kaisong Tian, Jiaru Fu, Yifei Yu, Zhiwei Guo, Yinyu Ma, Anqi Wei, Xiaoyue Yu*, Changyou Zhan*, Jun Qian*. Effects of drug-induced liver injury on the in vivo fate of liposomes. European Journal of Pharmaceutics and Biopharmaceutics, 2024, 201: 114389.
5. Qianqian Long#, Xinmin Zhao#, Lili Gao, Mengyuan Liu , Feng Pan, Xihui Gao, Changyou Zhan,Yang Chen, Jialei Wang* and Jun Qian*. Effects of surface IR783 density on the in vivo behavior and imaging performance of liposomes. Pharmaceutics, 2024, 16(6): 744.
6. Qianwen Shao, Tianhao Ding, Feng Pan, Guanghui Li, Shun Shen*, Jun Qian*, Changyou Zhan, Xiaoli Wei*. Protein corona mediated liposomal drug delivery for bacterial infection management. Asian Journal of Pharmaceutical Sciences，2022, 17, 855-866.
7. Guanghui Li#, Mengke Wang#, Tianhao Ding, Jing Wang, Tao Chen, Qianwen Shao, Kuan Jiang, Liping Wang, Yifei Yu, Feng Pan, Bin Wang*, Xiaoli Wei*, Jun Qian*, Changyou Zhan. cRGD enables rapid phagocytosis of liposomal vancomycin for intracellular bacterial clearance. Journal of Controlled Release, 2022, 344: 202-213.
8. Juan Guan#, Ercan Wu#, Pengpeng Jin, Shuangxing Hou, Jun Qian*, Weiyue Lu, Bo Yu, Changyou Zhan*. Interrogating preclinical study of liposomes: the effect of mouse strain reexamined. Journal of Controlled Release, 2021, 334, 178-187.
9. Zhuxuan Jiang, Jican Liu, Juan Guan, Huan Wang, Tianhao Ding, Jun Qian*, and Changyou Zhan*. Self-adjuvant effect by manipulating the bionano interface of liposome-based nanovaccines. Nano Letters, 2021, 21(11): 4744-4752.
